Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03819621
Other study ID # SAGM1005
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 30, 2019
Est. completion date August 20, 2019

Study information

Verified date August 2020
Source Moorfields Eye Hospital NHS Foundation Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will evaluate the degree of translational movement loss from orbital implant to ocular prosthesis. This will be measured using two software applications - Image J as well as the mediGrid smartphone app in measuring prosthesis motility by comparing it to the ruler as a "gold" standard.


Description:

The fit and function of an ocular prosthetic determines the effective motility (movement) within the patient's eye socket. A poor fitting ocular prosthesis will lead to poor motility, patient discomfort and increased mucus discharge, and can risk the integrity of the anterior surface of the implanted orbit. Currently the method to determine best fit of the ocular prosthesis is dependent upon the ocularist's skill in adding or subtracting material from the wax model that is replicated from an initial alginate impression of the patient's eye socket.

The proposal of this study is to utilise digital imaging to capture images to measure the motility of both the orbital implant and the ocular prosthesis. Two methods will be compared: excursion measurements on a photograph using digital software (Image J) versus use of a smart phone app (an iOS app known as mediGrid (IRISS Medical Technologies, UK; CE Marked, HIPAA compliant). This study will evaluate the degree of translational movement loss from orbital implant to ocular prosthesis and analysis will include comparisons between hydroxyapatite and acrylic implants and in patients without an orbital implant, also known as post-enucleation socket syndrome (PESS). A part of this study will also evaluate the accuracy of the two softwares Image J as well as the mediGrid smartphone app in measuring prosthesis motility by comparing it to the ruler as a "gold" standard.


Recruitment information / eligibility

Status Completed
Enrollment 57
Est. completion date August 20, 2019
Est. primary completion date July 18, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adults with surgery to remove one eye

- Able to give consent and understand the study

- Able to cooperate by following instructions (keeping head still, perform gaze movements)

- Enucleation was performed with the integrated implant technique (recti muscles sutured directly to the scleral cap or the mesh around the implant in a location corresponding to muscle insertion.

Exclusion Criteria:

- Radiotherapy to socket

- Chemotherapy

- Implant exposure repair

- Secondary orbital implant

- Concurrent socket pathology:

- Socket infection

- Socket exposure

- Giant papillary conjunctivitis

- Presence of ocular motility disorders on either side of the face, such as nystagmus, known muscle restrictive disorders (thyroid eye disease, previous trauma, idiopathic orbital inflammatory disease) and neurological disorders (cranial neuropathies, multiple sclerosis).

Study Design


Related Conditions & MeSH terms


Intervention

Device:
IRISS Medical Technologies mediGrid app
IRISS mediGrid is standalone software, loaded on a mobile electronic platform, which is intended to record and document ophthalmic and other bodily characteristics and to aid in the diagnosis of abnormalities.

Locations

Country Name City State
United Kingdom Moorfields Eye Hospital NHS Foundation Trust, 162 City Road London

Sponsors (1)

Lead Sponsor Collaborator
Moorfields Eye Hospital NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measurements of orbital implant and ocular prosthesis motility via the mediGrid app Orbital implant motility in patient with enucleated sockets will be measured with a mediGrid app. The app will evaluate the degree of translational movement loss from orbital implant to ocular prosthesis. 1 Month
See also
  Status Clinical Trial Phase
Completed NCT05093348 - Click2Print Artificial Eyes N/A
Completed NCT03925207 - Retrobulbar Block and/or General Anesthesia for Orbital Ball Implants After Enucleation Surgery.
Completed NCT05236049 - Use of an Allograft Set-up (SclerFIX) as Replacement of Sclera Graft for Support of Enucleation Implant Phase 1
Completed NCT03507426 - Retrobulbar Block Versus Ketamine Infusion for Post-enucleation Analgesia N/A